21571529|t|Amino-caprolactam gamma-secretase inhibitors showing potential for the treatment of Alzheimer's disease.
21571529|a|Herein we describe the structure-activity relationship (SAR) of amino-caprolactam analogs derived from amino-caprolactam benzene sulfonamide 1, highlighting affects on the potency of gamma-secretase inhibition, selectivity for the inhibition of APP versus Notch processing by gamma-secretase and selected pharmakokinetic properties. Amino-caprolactams that are efficacious in reducing the cortical Abeta(x-40) levels in FVB mice via a single 100 mpk IP dose are highlighted.
21571529	0	17	Amino-caprolactam	Chemical	-
21571529	84	103	Alzheimer's disease	Disease	MESH:D000544
21571529	169	186	amino-caprolactam	Chemical	-
21571529	208	245	amino-caprolactam benzene sulfonamide	Chemical	-
21571529	438	456	Amino-caprolactams	Chemical	-
21571529	503	514	Abeta(x-40)	Gene	11820
21571529	529	533	mice	Species	10090

